With this enhancement in the CureMD application, AOEs for specific tests like Cytology, AFP, and Blood Lead are provided at the individual test level rather than the order level. This enables more precise data entry for each test in the LabCorp interface.
With this enhancement in the CureMD application, users gain the flexibility to select multiple AOE responses when ordering lab tests via LabCorp. This facilitates accurate lab order submissions by allowing more detailed patient input.
With this enhancement in the CureMD application, a prompt checks for missing employer information when Worker’s Compensation is the claim type on LabCorp orders. This ensures proper billing and helps prevent delays associated with incomplete claims.
With this enhancement in the CureMD application, users navigate seamlessly to the Tumor Assessment tab from various other tabs within the Research section of a patient’s clinical details. This facilitates efficient tumor assessment management and supports compliance in clinical trials.
With this enhancement in the CureMD application, the system prompts the user to add an amount before saving a denial with $0. This helps prevent automatic resolution of denials without any payment being recorded.
With this enhancement in the CureMD application, users can generate a Good Faith Estimate (GFE) for uninsured or self-pay patients, providing a detailed breakdown of expected healthcare costs. This feature promotes transparency and helps patients understand their financial responsibility before receiving services.
With this enhancement in the CureMD application, clinicians are guided through an NCCN Concordance Check when ordering custom regimens, ensuring compliance with NCCN guidelines. The system offers a selection of verified NCCN regimens for comparison, helping to streamline the process
With this enhancement in the CureMD application, users can add subsequent timepoints to track tumor progress after the baseline assessment, with options for lesion measurement, fusion, splitting, and new lesion documentation. This functionality allows for comprehensive tracking across multiple timepoints.
With this enhancement in the CureMD application, users can document a Baseline Timepoint when adding a timepoint for the first time in Tumor Assessment, following RECIST guidelines. This includes fields for radiology details, target and non-target lesions, and more, providing comprehensive data entry for baseline assessments.
With this enhancement in the CureMD application, a "Tumor Assessment" button has been added to the Patient's Clinical side navbar, enabling quick access to the Tumor Assessment tab. Users with the appropriate permissions can easily navigate to this section for streamlined workflow.
Posted On: Jul 22, 2026
Posted On: Jul 21, 2026
Posted On: Jul 21, 2026
Posted On: Jul 14, 2026
Posted On: Jul 14, 2026
Posted On: Jul 14, 2026